×
ADVERTISEMENT

uveal melanoma

FDA Approves Uveal Melanoma Therapy That Targets Specific Cancer Cells

The FDA approved tebentafusp-tebn (Kimmtrak, Immunocore), a bispecific T-cell engager designed to redirect the ...

JANUARY 31, 2022

Pembrolizumab a “Viable” Option for Metastatic Uveal Melanoma

A case series of 10 patients with metastatic uveal melanoma suggests that pembrolizumab is associated with a mean ...

FEBRUARY 17, 2016

Load more